Filing Details
- Accession Number:
- 0001645470-19-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-15 09:36:01
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-15 09:36:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-12 | 1,000 | $0.02 | 21,132,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,137,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 2,500 | $0.02 | 21,140,123 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 2,500 | $0.02 | 21,142,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,147,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,157,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,162,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,167,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,172,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,177,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,182,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 1,000 | $0.02 | 21,183,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,193,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 1,000 | $0.02 | 21,194,193 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,204,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,209,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,219,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,229,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,234,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,244,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,254,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,259,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 5,000 | $0.02 | 21,264,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,274,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,284,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,294,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 15,000 | $0.02 | 21,309,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,319,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 10,000 | $0.02 | 21,329,623 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-12 | 15,000 | $0.02 | 21,344,623 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |